Parnax Lab

Parnax Lab EBITDA per Employee

The EBITDA per Employee of Parnax Lab (506128.BO) as of Nov 18, 2026 is 22.62 M INR. In the previous year, EBITDA per Employee was 19.64 M INR — a change of 15.19% (higher).

EBITDA per Employee

22.62 MINR

YoY

15.19%

Last updated:

EBITDA per Employee of Parnax Lab is 2025 22.62 M INR. EBITDA per Employee of Parnax Lab was 2024 19.64 M INR. It decreases by 15.19% higher compared to the previous year.

The Parnax Lab EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
9.33 M INR
Jan 1, 2019
8.52 M INR
Jan 1, 2020
5.36 M INR
Jan 1, 2021
8.29 M INR
Jan 1, 2022
19.19 M INR
Jan 1, 2023
19.22 M INR
Jan 1, 2024
19.64 M INR
Jan 1, 2025
22.62 M INR
The Parnax Lab EBITDA per Employee history
YEAREBITDA per EmployeeYoY
22.62 MINR+15.19%
19.64 MINR+2.14%
19.22 MINR+0.17%
19.19 MINR+131.54%
8.29 MINR+54.57%
5.36 MINR-37.04%
8.52 MINR-8.72%
9.33 MINR-12.27%
10.64 MINR+23.48%
8.61 MINR-17.79%
10.48 MINR+35.09%
7.76 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

EBITDA per Employee of Parnax Lab is 22.62 M INR in 2025.

EBITDA per Employee of Parnax Lab changed from 19.64 M INR to 22.62 M INR, representing a 15.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Parnax Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Parnax Lab

All Key Metrics — Parnax Lab